TEAS RF New Application

ABECMA

Celgene Corporation

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88202247
Filing Date: 11/21/2018

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88202247
MARK INFORMATION
*MARK ABECMA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ABECMA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Celgene Corporation
*STREET 86 Morris Avenue
*CITY Summit
*STATE
(Required for U.S. applicants)
New Jersey
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
07901
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER UK00003355015
       FOREIGN APPLICATION
       COUNTRY
United Kingdom
       FOREIGN FILING DATE 11/21/2018
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME Camille M. Miller
ATTORNEY DOCKET NUMBER CELG-1846US/
FIRM NAME Cozen O'Connor
INTERNAL ADDRESS Suite 2800
STREET 1650 Market Street
CITY Philadelphia
STATE Pennsylvania
COUNTRY United States
ZIP/POSTAL CODE 19103
PHONE 215-665-7273
FAX 2157012273
EMAIL ADDRESS cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Melanie A. Miller, J. Trevor Cloak, Chanel L. Lattimer, Brianne L. Polito, Ashley Kessler, Mayura Noordyke, Kevin Gibbs
CORRESPONDENCE INFORMATION
NAME Camille M. Miller
FIRM NAME Cozen O'Connor
INTERNAL ADDRESS Suite 2800
STREET 1650 Market Street
CITY Philadelphia
STATE Pennsylvania
COUNTRY United States
ZIP/POSTAL CODE 19103
PHONE 215-665-7273
FAX 2157012273
*EMAIL ADDRESS cmiller@cozen.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Camille M. Miller/
SIGNATORY'S NAME Camille M. Miller
SIGNATORY'S POSITION attorney
SIGNATORY'S PHONE NUMBER 215-665-7273
DATE SIGNED 11/21/2018



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88202247
Filing Date: 11/21/2018

To the Commissioner for Trademarks:

MARK: ABECMA (Standard Characters, see mark)
The literal element of the mark consists of ABECMA.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Celgene Corporation, a corporation of Delaware, having an address of
      86 Morris Avenue
      Summit, New Jersey 07901
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on United Kingdom application number UK00003355015, filed 11/21/2018.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.



The applicant's current Attorney Information:
      Camille M. Miller and Melanie A. Miller, J. Trevor Cloak, Chanel L. Lattimer, Brianne L. Polito, Ashley Kessler, Mayura Noordyke, Kevin Gibbs of Cozen O'Connor
      Suite 2800
      1650 Market Street
      Philadelphia, Pennsylvania 19103
      United States
      215-665-7273(phone)
      2157012273(fax)
      cmiller@cozen.com (authorized)
The attorney docket/reference number is CELG-1846US/.
The applicant's current Correspondence Information:
      Camille M. Miller
      Cozen O'Connor
      Suite 2800
      1650 Market Street
      Philadelphia, Pennsylvania 19103
      215-665-7273(phone)
      2157012273(fax)
      cmiller@cozen.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Camille M. Miller/   Date: 11/21/2018
Signatory's Name: Camille M. Miller
Signatory's Position: attorney
Payment Sale Number: 88202247
Payment Accounting Date: 11/21/2018

Serial Number: 88202247
Internet Transmission Date: Wed Nov 21 10:34:39 EST 2018
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2018112110343969
2888-88202247-6106229f8f6156c57df2e1f2f9
c50591a9cb7c9d8efc2b9f5eb6dc7fcc4242b3b3
-CC-11700-20181121102937326232

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed